Invasive mucormycosis during treatment for acute lymphoblastic leukaemia—successful management of two life-threatening diseases

A 5-year-old patient treated for acute lymphoblastic leukaemia (ALL) developed proven pulmonary invasive fungal disease (IFD) due to Actinomucor elegans. While completing ALL treatment according to AIEOP ALL protocol 2009 for further 15 months, antifungal treatment with liposomal amphotericin B and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Support Care Cancer
Egile Nagusiak: Trobisch, Andreas, Marterer, R., Gorkiewicz, G., Flaschberger, S., Lackner, H., Seidel, M., Sperl, D., Karastaneva, A., Kohlmaier, B., Egger, M., Urban, C., Benesch, M., Strenger, V.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Berlin Heidelberg 2019
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7083803/
https://ncbi.nlm.nih.gov/pubmed/31410599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-019-04962-3
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak